Initiation Archives - Page 152 of 272

1 minute read

Goldman Sachs Initiates Coverage On Tyler Technologies with Neutral Rating, Announces Price Target of $322

Today, 6:40 AM

Goldman Sachs analyst Gabriela Borges initiates coverage on Tyler Technologies (NYSE:TYL) with a Neutral rating and announces Price Target of $322.

TYL

1 minute read

Stifel Initiates Coverage On ZeroFox Holdings with Buy Rating, Announces Price Target of $6

By Benzinga Newsdesk

Today, 6:12 AM

Stifel analyst Brad Reback initiates coverage on ZeroFox Holdings (NASDAQ:ZFOX) with a Buy rating and announces Price Target of $6.

ZFOX

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For November 8, 2022

By Benzinga Insights

November 8, 10:43 AM

Upgrades

ACA

1 minute read

Deutsche Bank Initiates Coverage On Planet Labs with Buy Rating, Announces Price Target of $7

By Benzinga Newsdesk

November 8, 9:42 AM

Deutsche Bank analyst Edison Yu initiates coverage on Planet Labs (NYSE:PL) with a Buy rating and announces Price Target of $7.

1 minute read

Morgan Stanley Reinstates Equal-Weight on Verisk Analytics, Announces $170 Price Target

By Benzinga Newsdesk

November 8, 9:40 AM

Morgan Stanley analyst Toni Kaplan reinstates Verisk Analytics (NASDAQ:VRSK) with a Equal-Weight and announces $170 price target.

VRSK

1 minute read

Raymond James Initiates Coverage On Kymera Therapeutics with Market Perform Rating

By Benzinga Newsdesk

November 8, 8:17 AM

Raymond James analyst Steven Seedhouse initiates coverage on Kymera Therapeutics (NASDAQ:KYMR) with a Market Perform rating.

KYMR

1 minute read

Morgan Stanley Initiates Coverage On STMicroelectronics with Equal-Weight Rating

By Benzinga Newsdesk

November 8, 7:23 AM

Morgan Stanley analyst Lee Simpson initiates coverage on STMicroelectronics (NYSE:STM) with a Equal-Weight rating.

STM

1 minute read

Canaccord Genuity Initiates Coverage On Passage Bio with Buy Rating, Announces Price Target of $8

By Benzinga Newsdesk

November 8, 6:00 AM

Canaccord Genuity analyst Whitney Ijem initiates coverage on Passage Bio (NASDAQ:PASG) with a Buy rating and announces Price Target of $8.

PASG

1 minute read

Canaccord Genuity Initiates Coverage On Rocket Pharmaceuticals with Buy Rating, Announces Price Target of $53

By Benzinga Newsdesk

November 8, 5:59 AM

Canaccord Genuity analyst Whitney Ijem initiates coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) with a Buy rating and announces Price Target of $53.

RCKT

1 minute read

Canaccord Genuity Initiates Coverage On Regulus Therapeutics with Buy Rating, Announces Price Target of $9

By Benzinga Newsdesk

November 8, 5:57 AM

Canaccord Genuity analyst Whitney Ijem initiates coverage on Regulus Therapeutics (NASDAQ:RGLS) with a Buy rating and announces Price Target of $9.

RGLS